Skip to main content
×
Home
    • Aa
    • Aa

Complementary and alternative medicine in breast cancer patients

  • ZEINA NAHLEH (a1) (a2) and IMAD A. TABBARA (a3)
Abstract

Objective: Complementary and Alternative Medicine (CAM) is becoming increasingly popular among cancer patients, in particular those with breast cancer. It represents one of the fastest growing treatment modalities in the United States. Therefore, knowledge of CAM therapies is becoming necessary for physicians and other health care providers. CAM encompasses a wide range of modalities including special diet and nutrition, mind–body approaches, and traditional Chinese medicine.

Methods: We reviewed the biomedical literature on CAM use in breast cancer patients, using Medline search from 1975 until 2002. In addition, consensus reports and books on CAM and breast cancer were included in the review. We evaluated the prevalence of CAM use in breast cancer patients, the reasons cited for its use, the different available modalities, and the reported outcomes.

Results: Use of CAM in breast cancer patients ranges between 48% and 70% in the United States. The most commonly used CAM modalities include dietary supplements, mind–body approaches, and acupuncture. The reasons cited for using CAM were to boost the immune system, improve the quality of life, prevent recurrence of cancer, provide control over life, and treat breast cancer and the side effects of treatment. Several studies reported favorable results including improved survival, better pain control, reduced anxiety, improvement in coping strategies and significant efficacy in treating nausea and vomiting. Other less well-organized trials have reported either no benefit or negative effect of CAM and potential toxicity of some commercial products.

Significance of results: CAM is a growing field in health care and particularly among breast cancer patients. Knowledge of CAM by physicians, especially oncologists, is necessary. Oncologists should be willing to discuss the role of CAM with their patients and encourage patients to participate in well-organized research about CAM.

Copyright
Corresponding author
Corresponding author: Imad A. Tabbara, University of Virginia Health System, Division of Hematology/Oncology, P.O. Box 800716, Charlottesville, VA 22908-0716. E-mail: iat2b@virginia.edu
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

Adler, S.R. (1999). Complementary and alternative medicine use among women with breast cancer. Medical Anthropology Q, 13, 214222.

Arathuzik, D. (1994). Effects of cognitive behavioral strategies on pain in cancer patients. Cancer Nursing, 17, 207214.

Ashar, B. & Vargo, E. (1996). Shark cartilage induced hepatitis. Annals of Internal Medicine, 125, 780781.

Astin, J.A. (1998). Why patients use alternative medicine: Results of a national study. Journal of the American Medical Association, 279, 15481553.

Bahnson, C.B. (1980). Stress and cancer: The state of the art. Psychosomatics, 21(12), 975981.

Boon, H., Stewart, M., Kennard, & M.A., et al. (2000). Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. Journal of Clinical Oncology, 18(13), 25152521.

Bu-Abbas, A., Clifford, M.N., Walker, & R., et al. (1994). Marked antimutagenic potential of aqueous green tea extracts: Mechanism of action. Mutagenesis, 9, 325331.

Burnstein, H.J., Gelber, S., Guadagnoli, & E., et al. (1999). Use of alternative medicine by women with early stage breast cancer. New England Journal of Medicine, 340, 17331739.

Cassileth, B.R. (1999). Evaluating complementary and alternative therapies for cancer patients. CA Cancer Journal for Clinicians, 49, 362375.

Coates, A., Gebski, V., Signorini, & D., et al. (1992). Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. Journal of Clinical Oncology, 10, 18331838.

Coss, R.A., McGrath, P., & Caggiano, V. (1998). Alternative care: Patient choices for adjunct therapies within a cancer center. Cancer Practices, 6, 176181.

Crocetti, E., Crotti, N., Feltrin, & A., et al. (1998). The use of complementary therapies by breast cancer patients attending conventional treatment. European Journal of Cancer, 34, 324328.

Davis, H. (1986). Effects of biofeedback and cognitive therapy on stress in patients with breast cancer. Psychological Reports, 59, 967974.

Downer, S.M., Cody, M.M., McCluskey, & P., et al. (1994). Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. British Medical Journal, 309, 8689.

Dundee, J.W., Chestnut, W.N., Ghaly, & R.G., et al. (1986). Traditional Chinese acupuncture: A potentially useful antiemetic?British Medical Journal, 293, 583584.

Eisenberg, D.M., Kessler, R.C., Foster, & C., et al. (1993). Unconventional medicine in the United States: Prevalence, costs, and patterns of use. New England Journal of Medicine, 328, 246252.

Ernst, E. & Cassileth, B.R. (1998). The prevalence of complementary/alternative medicine in cancer: A systematic review. Cancer, 83, 777782.

Fraser, S.C., Ramirez, A.J., Ebbs, & S.R., et al. (1993). A daily diary for quality of life measurement in advanced breast cancer trials. British Journal of Cancer, 67, 341346.

Gao, Y.T., McLaughlin, J.K., Blot, & W.J., et al. (1994). Reduced risk of esophageal cancer associated with green tea consumption. Journal of the National Cancer Institute, 86, 855858.

Gogos, C.A., Giropoulous, P., Salsa, & B., et al. (1998). Dietary omega 3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: A randomized control trial. Cancer, 82, 395402.

Goodwin, P.J., Leszcz, M., Ennis, & M., et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine, 345, 17191726.

Gotay, C.C. & Dumitriu, D. (2000). Health food recommendations for breast cancer patients. Archives in Family Medicine, 9, 692698.

Greer, S. & Silberfarb, P.M. (1982). Psychological concomitants of cancer: Current state of research. Psychologic Medicine, 12, 563573.

Irvine, D., Brown, B., Crooks, & D., et al. (1991). Psychosocial adjustment in women with breast cancer. Cancer, 67, 10971117.

Jacobson, J.S., Workman, S.B., & Kronenberg, F. (2000). Research on complementary/alternative medicine for patients with breast cancer: A review of the biomedical literature. Journal of Clinical Oncology, 18(13), 668683.

Klaunig, J.E. (1992). Chemopreventive effects of green tea components on hepatic carcinogenesis. Preventive Medicine, 21, 510519.

Koch, C.J. & Bigalow, J.E. (1978). Toxicity, radiation sensitivity modification, and metabolic effects of Dehydroascobate and Ascorbate in mammalian cells. Journal of Cell Physiology, 94, 299306.

Kurbacher, C.M., Wagner, U., Kolster, & B., et al. (1996). Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast cancer cell lines in vitro. Cancer Letters, 103, 183189.

Lee, H.P., Gourley, L., Duffee, & S.W., et al. (1991). Dietary effects on breast cancer risk in Singapore. Lancet, 337, 11971200.

Lee, M.M., Lin, S.S., Wrensch, & M.R., et al. (2000). Alternative therapies used by women with breast cancer in four ethnic populations. Journal of the National Cancer Institute, 92(1), 4247.

Lerner, I.J. & Kennedy, B.J. (1992). The prevalence of questionable methods of cancer treatment in the United States. CA Cancer Journal for Clinicians, 42, 181191.

Lockwood, K., Moesgaard, S., Hanioka, & T., et al. (1994). Apparent partial remission of breast cancer in “high risk” patients supplemented with nutritional oxidants, essential fatty acids and coenzyme Q10. Molecular Aspects of Medicine, 15, S231S240.

Miller, D.R., Anderson, G.T., Stark, & J.J., et al. (1998). Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. Journal of Clinical Oncology, 16, 36493655.

Mukhtar, H., Katiyar, S.K., & Agarwal, R. (1994). Green tea and skin-anticarcinogenic effects. Journal of Investigational Dermatology, 102, 37.

Munstedt, K., Kirsh, K., Milch, & W., et al. (1996). Unconventional cancer therapy: Survey of patients with gynecological malignancy. Archives in Gynecology and Obstetrics, 258, 8188.

Newman, V., Rock, C.L., Faerber, & S., et al. (1998). Dietary supplements used by women at risk of breast cancer recurrence. The women's healthy eating and living study group. Journal of the American Diet Association, 98, 285292.

Nortier, J.L., Martinez, M.C., Schmeiser, & H.H., et al. (2000). Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). New England Journal of Medicine, 342, 16861692.

Parker, S.L., Tong, T., Bolden, & S., et al. (1997). Cancer statistics. CA Cancer Journal for Clinicians, 47, 527.

Richardson, M.A., Sanders, T., Palmer, & J.L., et al. (2000). Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology, 18(13), 25052514.

Risberg, T., Lund, E., Wist, & E., et al. (1998). Cancer patients use of unproven therapy: A 5-year follow up study. Journal of Clinical Oncology, 16, 612.

Ruschitzka, F., Meier, P.J., Turina, & M., et al. (2000). Acute heart transplant rejection due to Saint John's wort. Lancet, 355, 548549.

Schimpff, S.C. (1997). Complementary medicine. Current Opinions in Oncology, 9, 327331.

Spaulding-Albright, N. (1997). A review of some herbal and related products commonly used in cancer patients. Journal of the American Diet Association, 97, S208S215.

Spiegel, D. & Bloom, J.R. (1983). Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosomatic Medicine, 45, 333339.

Stammler, G. & Volm, M. (1997). Green tea catechins have modulating effects on the activity of doxorubicin in drug resistant cell lines. Anticancer Drugs, 8, 265268.

Tagliafferi, M., Cohen, I., & Tripathy, D. (2001). Complementary and alternative medicine in early stage breast cancer. Seminars in Oncology, 28(1), 121134.

Walker, L.G., Heys, S.D., Walker, & M.B., et al. (1999). Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer. European Journal of Cancer, 35(13), 17831788.

Weeks, J. (1992). Quality of life assessment: Performance status upstaged?Journal of Clinical Oncology, 10, 18271829.

Wyatt, G.K., Friedman, L.L., Given, & C.W., et al. (1999). Complementary therapy use among older cancer patients. Cancer Practices, 7(3), 136144.

Zanolla, R., Monzeglio, C., Balzarini, & A., et al. (1984). Evaluation of the results of 3 different methods of postmastectomy lymphedema. Journal of Surgical Oncology, 26, 210213.

Zhang, S., Hunter, D.J., Forman, & M.R., et al. (1999). Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. Journal of the National Cancer Institute, 91, 547556.

Ziegler, R.G., Hoover, R.N., Pike, & M.C., et al. (1993). Migration patterns and breast cancer risk in Asia-American women. Journal of the National Cancer Institute, 85, 18191827.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Palliative & Supportive Care
  • ISSN: 1478-9515
  • EISSN: 1478-9523
  • URL: /core/journals/palliative-and-supportive-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 2
Total number of PDF views: 13 *
Loading metrics...

Abstract views

Total abstract views: 150 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 29th May 2017. This data will be updated every 24 hours.